SeouLinBioscienceCO.,LTD. Q3 revenue KRW 25.1 billion, profit from the main business KRW 2.1 billion
AI summary · Not investment advice
Seorin Bio sold KRW 25.1 billion of goods in Q3 and earned KRW 2.1 billion from its main business, up 166.4% from a year earlier and back in the black from the prior quarter.
Operating profit · 3 months
KRW 2.1 billion
Key facts
- Revenue (3 months)
- KRW 25.1 billion
- Net income (3 months)
- KRW 1.4 billion
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 22.9 billion
- Revenue (year to date)
- KRW 65.4 billion
- Operating profit (prior-year 3 months)
- KRW 784.7 million
- Operating profit (year to date)
- KRW 1.7 billion
- Net income (prior-year 3 months)
- KRW 755.3 million
- Net income (year to date)
- KRW 1.9 billion
Commentary
AI commentary · Not investment advice
What happened
Seorin Bio reported its consolidated results for the third quarter of 2026. Sales for the 3 months were KRW 25.09 billion, up 9.7% from KRW 22.87 billion a year earlier. They rose 20.6% from the previous quarter.
In the company's terms
Operating profit (profit from the core business) for the 3 months was KRW 2.09 billion. A year earlier it was KRW 784.7 million, so it rose 166.4%. The company had a loss in the previous quarter and returned to a profit this quarter.
What changes for shareholders
Net income (final profit after taxes and other costs) for the 3 months was KRW 1.38 billion. A year earlier it was KRW 755.3 million, so it rose 82.6%. It rose 303.0% from the previous quarter.
For the year to date (Jan 1 to Sep 30), sales were KRW 65.42 billion. Operating profit was KRW 1.67 billion. Net income was KRW 1.87 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
S